KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Markel (MKL) Cash & Equivalents (2016 - 2026)

Markel has reported Cash & Equivalents over the past 18 years, most recently at $3.7 billion for Q1 2026.

  • Quarterly Cash & Equivalents fell 12.24% to $3.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Mar 2026, down 12.24% year-over-year, with the annual reading at $4.0 billion for FY2025, 7.37% up from the prior year.
  • Cash & Equivalents was $3.7 billion for Q1 2026 at Markel, down from $4.0 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $4.4 billion in Q3 2023 and troughed at $3.5 billion in Q2 2024.
  • The 5-year median for Cash & Equivalents is $3.9 billion (2024), against an average of $3.9 billion.
  • Year-over-year, Cash & Equivalents rose 22.99% in 2023 and then fell 18.47% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $4.1 billion in 2022, then decreased by 9.44% to $3.7 billion in 2023, then fell by 1.45% to $3.7 billion in 2024, then grew by 7.37% to $4.0 billion in 2025, then dropped by 7.17% to $3.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MKL's Cash & Equivalents are $3.7 billion (Q1 2026), $4.0 billion (Q4 2025), and $4.0 billion (Q3 2025).